LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

Начало・Списък с акции・Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Inc

Затворен

СекторЗдравеопазване

27.31 4.12

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

25.5

Максимум

27.81

Ключови измерители
By Trading Economics
Приходи	23M 7.4M
Продажби	18M 99M
EPS	0.06
Марж на печалбата	7.468
Служители	342
EBITDA	23M 11M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+14.68% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	794M 3.2B
Предишно отваряне	23.19
Предишно затваряне	27.31

Настроения в новините

By Acuity

50%

190 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

12.42 / 14.93 Подкрепа & съпротива

Arcutis Biotherapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.11.2025 г., 19:25 ч. UTC

Придобивния, сливания и поглъщания

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18.11.2025 г., 18:09 ч. UTC

Придобивния, сливания и поглъщания

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18.11.2025 г., 17:39 ч. UTC

Придобивния, сливания и поглъщания

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18.11.2025 г., 16:25 ч. UTC

Значими двигатели на пазара

Diginex Rises on Deal With Digital Asset Platform Evident

18.11.2025 г., 23:56 ч. UTC

Пазарно говорене

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18.11.2025 г., 23:39 ч. UTC

Пазарно говорене

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18.11.2025 г., 22:59 ч. UTC

Пазарно говорене

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18.11.2025 г., 22:08 ч. UTC

Пазарно говорене

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18.11.2025 г., 22:03 ч. UTC

Придобивния, сливания и поглъщания

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18.11.2025 г., 22:03 ч. UTC

Печалби

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

18.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

18.11.2025 г., 21:15 ч. UTC

Пазарно говорене

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18.11.2025 г., 20:46 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18.11.2025 г., 20:13 ч. UTC

Пазарно говорене

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18.11.2025 г., 19:48 ч. UTC

Пазарно говорене

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18.11.2025 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18.11.2025 г., 18:29 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18.11.2025 г., 18:18 ч. UTC

Пазарно говорене

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

18.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

18.11.2025 г., 17:19 ч. UTC

Пазарно говорене

Печалби

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18.11.2025 г., 17:06 ч. UTC

Печалби

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18.11.2025 г., 16:06 ч. UTC

Придобивния, сливания и поглъщания

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18.11.2025 г., 15:59 ч. UTC

Печалби

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18.11.2025 г., 15:35 ч. UTC

Придобивния, сливания и поглъщания

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18.11.2025 г., 15:35 ч. UTC

Придобивния, сливания и поглъщания

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Сравнение с други в отрасъла

Ценова промяна

Arcutis Biotherapeutics Inc Прогноза

Ценова цел

By TipRanks

14.68% нагоре

12-месечна прогноза

Среден 28.67 USD 14.68%

Висок 32 USD

Нисък 21 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Arcutis Biotherapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Arcutis Biotherapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

12.42 / 14.93Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bullish event.

Настроение

By Acuity

190 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.